A detailed history of Beaird Harris Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beaird Harris Wealth Management, LLC holds 2,732 shares of ABBV stock, worth $491,760. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,732
Previous 2,057 32.81%
Holding current value
$491,760
Previous $352,000 53.13%
% of portfolio
0.05%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 02, 2024

BUY
$163.84 - $199.33 $110,592 - $134,547
675 Added 32.81%
2,732 $539,000
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $8,668 - $10,122
-56 Reduced 2.65%
2,057 $352,000
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $30,525 - $34,781
191 Added 9.94%
2,113 $384,000
Q4 2023

Feb 27, 2024

BUY
$137.6 - $154.97 $6,329 - $7,128
46 Added 2.45%
1,922 $297,000
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $10,286 - $11,908
77 Added 4.28%
1,876 $279,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $662 - $824
5 Added 0.28%
1,799 $242,000
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $9,255 - $10,658
-64 Reduced 3.44%
1,794 $285,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $10,096 - $12,108
73 Added 4.09%
1,858 $300,000
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $62,005 - $71,115
462 Added 34.92%
1,785 $240,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $172,300 - $219,049
-1,252 Reduced 48.62%
1,323 $203,000
Q1 2022

May 27, 2022

BUY
$131.98 - $163.75 $527 - $655
4 Added 0.16%
2,575 $417,000
Q4 2021

May 17, 2022

BUY
$107.43 - $135.93 $276,202 - $349,476
2,571 New
2,571 $348,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Beaird Harris Wealth Management, LLC Portfolio

Follow Beaird Harris Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaird Harris Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaird Harris Wealth Management, LLC with notifications on news.